Sonnet Biotherapeutics - IL-18臨床試驗表明，儘管耐受性良好，

快訊 · 06/13 20:05

Sonnet Biotherapeutics - Il-18 Clinical Trials Have Shown That, Although It Is Well Tolerated, Il-18 Has Poor Efficacy in Treatment of Cancers

Sonnet Biotherapeutics - IL-18臨床試驗表明，儘管耐受性良好，IL-18在治療癌症方面療效較差。